The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Dario Sorrentino

DECM - Chair of Gastroenterology

University of Udine Medical School

Italy

[email]@uniud.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • DECM - Chair of Gastroenterology, University of Udine Medical School, Italy. 2011
  • Department of Clinical and Experimental Pathology, University of Udine School of Medicine, Udine, Italy. 1999 - 2010
  • Cattedra di Gastroenterologia, Azienda Ospedaliero-Universitaria, Padiglione Scrosoppi, Via Colugna, Italy. 2009

References

  1. Acute Severe Colitis: Infliximab and/or Cyclosporine? Fabro, M., Szabo, H., Terrosu, G., Avellini, C., Tabuso, M., Fiorino, G., Sorrentino, D. Curr. Drug. Targets (2011) [Pubmed]
  2. Anti-TNF's for postoperative recurrence in Crohn's disease: the if's and how's. Sorrentino, D., Paviotti, A., Fiorino, G. Curr. Drug. Targets (2010) [Pubmed]
  3. Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn's disease. Sorrentino, D., Paviotti, A., Terrosu, G., Avellini, C., Geraci, M., Zarifi, D. Clin. Gastroenterol. Hepatol. (2010) [Pubmed]
  4. Anti-TNF's for Postoperative Recurrence in Crohn's Disease: The If's and How's. Sorrentino, D., Paviotti, A., Fiorino, G. Curr. Drug. Targets (2009) [Pubmed]
  5. Role of biologics and other therapies in stricturing Crohn's disease: what have we learnt so far? Sorrentino, D. Digestion (2008) [Pubmed]
  6. Infliximab in Crohn's disease: a look at the (not so distant) future. Sorrentino, D., Terrosu, G., Avellini, C. Dig. Liver. Dis (2008) [Pubmed]
  7. Selective effect of infliximab on the inflammatory component of a colonic stricture in Crohn's disease. Sorrentino, D., Avellini, C., Beltrami, C.A., Pasqual, E., Zearo, E. Int. J. Colorectal. Dis (2006) [Pubmed]
  8. Prevention of postoperative recurrence of Crohn's disease by infliximab. Sorrentino, D., Terrosu, G., Avellini, C., Beltrami, C.A., Bresadola, V., Toso, F. Eur. J. Gastroenterol. Hepatol (2006) [Pubmed]
  9. Heart-touching Chilaiditi's syndrome. Sorrentino, D., Bazzocchi, M., Badano, L., Toso, F., Giagu, P. World J. Gastroenterol. (2005) [Pubmed]
  10. Cavernous transformation of the portal vein associated to multiorgan developmental abnormalities. Sorrentino, D., Labombarda, A., Debiase, F., Trevisi, A., Giagu, P. Liver Int. (2004) [Pubmed]
  11. Colonic sarcoidosis, infliximab, and tuberculosis: a cautionary tale. Sorrentino, D., Avellini, C., Zearo, E. Inflamm. Bowel Dis. (2004) [Pubmed]
  12. Scientific publications in gastroenterology and hepatology in Western Europe, USA and Japan in the years 1992-1996: a global survey. Sorrentino, D., De Biase, F., Trevisi, A., Bartoli, E. Digestion (2000) [Pubmed]
  13. Colorectal cancer screening in Italy: feasibility and cost-effectiveness in a model area. Sorrentino, D., Paduano, R., Bernardis, V., Piccolo, A., Bartoli, E. Eur. J. Gastroenterol. Hepatol (1999) [Pubmed]
 
WikiGenes - Universities